- Home
- ->
- Industry News
Jul 21, 2020: CMS' recent proposal to loosen Medicaid rules to facilitate value-based contracts for drugs could have wide-ranging implications for the 340B program, independent physicians' Medicare drug reimbursement, and patients' expenses.
Outside link:
"With many patients, there are trade-offs they have to weigh that lead to noncompliance"